More than 150 deaths have been reported after weight loss drug use, according to information dated August 6, 2026. The reported total is described only as exceeding 150. The report does not identify the drugs involved, the patients affected, or the exact number of cases.
All of the deaths in the report took place after weight loss drug use. The report does not identify which weight loss drugs were involved. It also does not explain how the use of the drugs was reported.
The report gives no information about the patients who died. Their ages, genders, and health conditions are not included. The report also does not say whether the patients were using the drugs as prescribed or without a prescription.
The names of the drugs are not listed. The report does not mention the manufacturer of any weight loss medication. It also does not provide information about dosage or how long the drugs were used before the reported deaths.
The report does not state which country or countries submitted the death reports. It does not indicate whether the deaths were confirmed by doctors or documented in official records. It also does not say whether the deaths occurred during a short period or over many months.
Related reading: Germany first EU country to launch Wegovy oral GLP-1, Hers Adds an AI Tool to Help Women Navigate Weight Loss and GLP-1 Use, CVS Health enhances its direct-to-consumer weight management offerings, Eli Lilly Surpasses Wall Street Estimates on Injectable GLP-1 Drugs.